Login / Signup

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

Ashley M HopkinsAndrew RowlandMichael J Sorich
Published in: BMC medicine (2018)
Fifteen percent of the sampled clinical trials were available for data sharing 2 years after publication of primary results of the trial. Key issues limiting data sharing include a large proportion of industry sponsors who do not have a data sharing policy/process, and data sharing policy conditions that exclude access on the basis of ongoing follow-up and regulatory activity.
Keyphrases
  • electronic health record
  • clinical trial
  • big data
  • social media
  • health information
  • healthcare
  • public health
  • mental health
  • transcription factor
  • data analysis
  • study protocol
  • machine learning
  • open label
  • double blind